MOUNTAIN VIEW, Calif.,
Oct. 26, 2016 /PRNewswire/ --
Omnicell, Inc. (NASDAQ: OMCL) today announced a partnership with
two prestigious academic medical centers to enhance clinical staff
workflows and foster improved patient care. Both
Dartmouth-Hitchcock (Lebanon,
N.H.) and Stanford Health Care (Palo Alto, Calif.) are deploying the Company's
solutions to upgrade medication management technology to optimize
patient outcomes.
Academic medical centers play a leadership role in improving the
standards of medication delivery and patient care to ensure the
healthiest, fastest, and safest discharge. Managing medications
from arrival into the hospital, through the hospital-based pharmacy
to the patient bedside is a key component to the success of this
process. Additionally, having solutions that are interoperable with
other systems in the hospital, including the electronic health
record, helps streamline workflows for nurses and other providers
so they are able to spend more time with the patient as opposed to
navigating administrative tasks.
Stanford Health Care will replace its existing dispensing
cabinets with Omnicell solutions, with plans to install similar
automated medication management technologies in its new hospital
that is expected to be completed by 2018. It also plans to add new
solutions to promote enhanced security for controlled substances in
the next few months to improve workflows and ensure medication
safety in the operating room.
By updating its medication management technology,
Dartmouth-Hitchcock maintains its dedication to hospital security
and safety. The hospital network serves patients across northern
New England, and will be implementing technology that includes
central pharmacy automation, enterprise medication management
capabilities, and automated medication dispensing on hospital
floors. These technologies support enterprise-wide visibility of
inventory and set the stage for optimizing operations across
numerous health facilities.
Beyond the focus on short-term planning, hospitals today are
trying to forecast how care might change over the next 25 years.
With more attention being paid to physical environments and how
patients move within the hospital, there is a renewed focus on
making jobs easier for all employees who engage patients – whether
doctors, nurses, pharmacists, or administrators. Omnicell
automation, which includes unique features for simplifying the
medication management process, supports the goal of enabling
greater patient interaction by reducing the amount of time spent on
administrative and other non-patient facing activities.
"As we expand to serve over 4,000 hospitals in the U.S., we're
pleased to support these prestigious academic institutions on both
sides of the country. Interoperability and optimal medication
management are central to not just academic facilities, but all
hospitals looking to streamline workflows and improve patient
safety," said J. Christopher Drew,
president, North American Automation and Analytics at Omnicell.
"Both institutions embody innovation as they continue to make
advancements in the medical field to deliver excellent patient
care. We embrace the opportunity to meet the short- and long-term
needs of these facilities."
About Dartmouth-Hitchcock
DARTMOUTH-HITCHCOCK (D-H) is a nonprofit academic health system
serving communities in northern New England. D-H provides access to
more than 1,000 primary care doctors and specialists in almost
every area of medicine at Dartmouth-Hitchcock Medical Center; the
Norris Cotton Cancer Center, the Children's Hospital at
Dartmouth-Hitchcock, four affiliate hospitals, 24 ambulatory
clinics and through the Visiting Nurse and Hospice for VT and NH.
The D-H system trains nearly 400 residents and fellows annually,
and performs world-class research, in partnership with the Audrey
and Theodor Geisel School of Medicine at Dartmouth and the White
River Junction VA Medical Center.
About Stanford Health Care
Stanford Health Care seeks to heal humanity through science and
compassion, one patient at a time, through its commitment to care,
educate and discover. Stanford Health Care delivers clinical
innovation across its inpatient services, specialty health centers,
physician offices, virtual care offerings and health plan
programs.
Stanford Health Care is part of Stanford
Medicine, a leading academic health system that includes the
Stanford University School of Medicine,
Stanford Health Care, and Stanford Children's Health, with Lucile
Packard Children's Hospital. Stanford
Medicine is renowned for breakthroughs in treating cancer,
heart disease, brain disorders and surgical and medical conditions.
For more information, visit:
https://www.stanfordhealthcare.org.
About Omnicell
Since 1992, Omnicell (NASDAQ: OMCL) has been inspired to create
safer and more efficient ways to manage medications and supplies
across all care settings. As a leader in medication and supply
dispensing automation, central pharmacy automation, IV robotics,
analytics software, and medication adherence and packaging systems,
Omnicell is focused on improving care across the entire healthcare
continuum—from the acute care hospital setting, to post-acute
skilled nursing and long-term care facilities, to the patient's
home.
Over 4,000 customers worldwide use Omnicell automation and
analytics solutions to increase operational efficiency, reduce
medication errors, deliver actionable intelligence and improve
patient safety. The recent acquisition of Aesynt adds distinct
capabilities, particularly in central pharmacy and IV robotics,
creating the broadest medication management product portfolio in
the industry.
The Omnicell SureMed solution provides innovative medication
adherence packaging to help reduce costly hospital readmissions.
These medication adherence solutions are used by over 17,000
institutional and retail pharmacies in North America and the United
Kingdom. These pharmacies are served via the Company's sales
channels and our solutions enable them to maintain high accuracy
and quality standards in medication dispensing and administration
while optimizing productivity and controlling costs.
For more information about Omnicell, Inc. please
visit www.omnicell.com.
OMCL-G
Editor's Notes:
- All Omnicell news releases (financial, acquisitions, products,
technology etc.) are issued exclusively by PR Newswire and are
immediately thereafter posted on the company's external
website, omnicell.com.
- Omnicell and the Omnicell logo design are registered trademarks
of Omnicell, Inc.
- All other brand or product names may be trademarks or
registered trademarks of their respective companies.
Logo -
http://photos.prnewswire.com/prnh/20120731/SF48971LOGO-a
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/leading-academic-medical-centers-upgrade-medication-management-technology-to-increase-patient-safety-and-promote-innovation-300351953.html
SOURCE Omnicell, Inc.